COVEREDENTITY+

Serial Number 99230728
681

Registration Progress

Application Filed
Jun 12, 2025
Under Examination
Approved for Publication
Published for Opposition
Jan 13, 2026
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Feb 14, 2026 45 days

Trademark Image

COVEREDENTITY+

Basic Information

Serial Number
99230728
Filing Date
June 12, 2025
Published for Opposition
January 13, 2026
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Dec 22, 2025
Application
Pending
Classes
042

Rights Holder

CareMetx, LLC

16
Address
6931 Arlington Road
Suite 400
Bethesda, MD 20814

Ownership History

CareMetx, LLC

Original Applicant
16
Bethesda, MD

Legal Representation

Attorney
NANCY LAPIDUS

USPTO Deadlines

Next Deadline
45 days remaining
Non-Final Action E-Mailed
Due Date
February 14, 2026
Extension Available
Until May 14, 2026

Application History

12 events
Date Code Type Description Documents
Dec 11, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 11, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 11, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 11, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 11, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 14, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 14, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 14, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 31, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 19, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 12, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 12, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Platform as a service (PaaS) services featuring software for a centralized integration platform designed to connect healthcare providers, hub service providers, non-dispensing pharmacies, dispensing pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to enable prescriptions and enrollment forms to be routed through a coordinated workflow that supports prescription intake and validation, benefit eligibility and verification, prior-authorization, patient consent, hub service initiation, pharmacy triage, and synchronized status updates for the purpose of streamlining and accelerating patient access to therapy
First Use Anywhere: Mar 19, 2025
First Use in Commerce: Mar 19, 2025

Additional Information

Pseudo Mark
COVEREDENTITY PLUS
Pseudo Mark
COVERED ENTITY PLUS

Classification

International Classes
042